OHSU researchers assemble comprehensive atlas of human gene mutations
April 13, 2023
With hundreds of tissue donors, it is the most extensive guide ever created; could lead to better diagnosis, treatment of diseases associated with ‘bad luck or bad habits.’
Pacific Northwest National Laboratory
April 04, 2023
Scientists at PNNL use state-of-the-art nuclear magnetic resonance capabilities to conduct proteomic research such as identifying breast cancer suppressor proteins. PNNL is teaming with OHSU to form the Precision Medicine Innovation Co-Laboratory. (Pacific Northwest National Laboratory)
OHSU strongly recommends masks in health care settings
March 31, 2023
Masks will still be required in certain areas, after April 3.
MRI innovation for the first time reveals cells’ energy activity in organs and tissues
March 31, 2023
OHSU research opens up new possibilities for brain imaging, detecting cancer, monitoring treatment.
Las evaluaciones de uso de tabaco cayeron durante la pandemia del COVID-19, y no han recuperado sus niveles anteriores
March 28, 2023
OHSU encabeza un estudio de alcance nacional para averiguar en qué afectó la pandemia las conversaciones de los pacientes con respecto al uso de tabaco, financiado en parte por la iniciativa Cancer MoonshotSM del National Cancer Institute.
Tobacco use assessments dropped during COVID-19 pandemic, have not recovered
March 28, 2023
OHSU leads national study on how pandemic affected patient discussions about tobacco use; funded in part by the National Cancer Institute’s Cancer Moonshot initiative.
New end-of-life doula services focus on rural, houseless populations
March 24, 2023
OHSU School of Nursing alum aims to make end-of-life a social, not medical event.
Tough on Cancer ad
March 16, 2023
Tough on Cancer ad, studio, Dr. Druker, Gert Boyle. (OHSU/Fritz Liedtke)
Study reveals limitations in evaluating gene editing technology in human embryos
March 07, 2023
OHSU-led research identifies new scientific hurdles in using gene repair to prevent inherited disease.
OHSU encabeza una iniciativa para que los ensayos sobre cáncer sean más inclusivos
March 06, 2023
la Dra. Eneida Nemecek, M.B.A., profesora en OHSU School of Medicine y directora médica de investigación clínica en el OHSU Knight Cancer Institute recibió una subvención de tres años por $625,000 del fondo de equidad en salud y diversidad en STEM de Genentec para llevar los beneficios de los ensayos clínicos a las personas de comunidades desatendidas. (OHSU)
